Skip to content

The Clinical Efficacy and Mechanism of Action of Electroacupuncture in the Treatment of Vascular Erectile Dysfunction

The Clinical Efficacy and Mechanism of Action of Electroacupuncture in the Treatment of Vascular Erectile Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001456
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-06-22
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular erectile dysfunction

Interventions

Control Group:Placebo Electroacupuncture

Sponsors

Shanghai University of Traditional Chinese Medicine Affiliated Longhua Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age between 20 and 60 years old; (2) Meets the diagnostic criteria for vascular erectile dysfunction; (3) Has not used PDE5 inhibitors or other treatments related to erectile dysfunction in the past month prior to treatment; (4) Is conscious, has basic reading and writing abilities, and can complete the questionnaire; (5) Physical examination shows no significant abnormalities or underdevelopment of the penis; (6) Voluntarily participates in the study, signs the informed consent form, and commits to receiving treatment as prescribed during the study period.

Exclusion criteria

Exclusion criteria: (1) History of genitourinary system tumors or other tumors; (2) Concurrent genitourinary system diseases or related surgical history; (3) History of severe pelvic trauma, pelvic radiotherapy, or other trauma; (4) Concurrent severe cardiovascular diseases, hematological disorders, or impaired liver or kidney function; (5) History of AIDS, syphilis, gonorrhea, hepatitis B, or other infectious diseases; (6) History of bacterial infections (e.g., pneumonia, urinary tract infections) or viral infections, or autoimmune diseases such as rheumatoid arthritis, tissue necrosis, which may affect the observation of inflammatory markers; (7) Currently taking immunosuppressive agents, glucocorticoids, nitrate medications, or other drugs that may affect the observation of blood NO levels; (8) Suffering from mental illness, dementia, or severe cognitive impairment, unable to cooperate with treatment and assessment; (9) Diagnosed with neuropathic ED or other organic ED; (10) Diagnosed with psychogenic ED by clinical examination; (11) Partner has severe sexual dysfunction; (12) Ulcers, skin infections at acupuncture sites, or allergies to stainless steel acupuncture needles or metals; (13) Currently participating in other clinical trials that may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
International Index of Erectile Function-5-item scale;

Secondary

MeasureTime frame
International Index of Erectile Function - Erectile Function Domain Scale;Erectile Rigidity Assessment Scale;The Erectile Quality Questionnaire Scale;Traditional Chinese Medicine Symptom Scale;The Erectile Dysfunction Quality of Life Scale;

Countries

China

Contacts

Public ContactChen Yue Lai

Shanghai University of Traditional Chinese Medicine Affiliated Longhua Hospital

chenyuelai@163.com13020193726

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026